6.15 (2.82%)
6.05 (2.77%) 10.50 am | 13 Mar 2012 | Source: CNBC-TV18
In an exclusive interview to CNBC-TV18, Kiran Mazumdar Shaw of Biocon says that the breakup with Pfizer will not have any short-term impact on revenue...
9.59 pm | 12 Mar 2012 | Source: CNBC-TV18
The deal between Biocon and Pfizer to market a range of insulin products may be in crisis. Vikas Dandekar, the India Bureau Chief of PharmAsia News wh...